Aurora Posts Q2 Earnings, Touts 562% Spike In 'International Medical' Cannabis Sales

Aurora Cannabis (NYSE: ACB) released its second-quarter fiscal earnings report Thursday afternoon. Here's what we learned:

  • Total cannabis net hovered $70.3 million, excluding provisions of $2.7 million
  • That's up 11% over the second quarter of 2020
  • Medical cannabis net revenue reached $38.9 million — up 42% versus the second quarter of 2020
  • That jump was due to a 562% increase in high margin international medical
  • Aurora experienced an adjusted EBITDA loss of $12.1 million
  • That's an improvement of …

Full story available on Benzinga.com

More Aurora Posts Q2 Earnings, Touts 562% Spike In 'International Medical' Cannabis Sales